Literature DB >> 187625

Morphology and incidence of childhood tumours.

H B Marsden.   

Abstract

Entities:  

Mesh:

Year:  1976        PMID: 187625      PMCID: PMC476265          DOI: 10.1136/jcp.29.11.1016

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  8 in total

1.  Adrenogenital syndrome in a male child due to adrenocortical tumor; report of case with hemihypertrophy and subsequent development of embryoma (Wilms' tumor).

Authors:  H A RIEDEL
Journal:  Pediatrics       Date:  1952-07       Impact factor: 7.124

2.  Incidence of malignant tumors in U. S. children.

Authors:  J L Young; R W Miller
Journal:  J Pediatr       Date:  1975-02       Impact factor: 4.406

3.  Tumors of childhood in Ibadan, Nigeria.

Authors:  A O Williams
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

4.  Nephroblastoma: possible index cancer of childhood.

Authors:  M D Innis
Journal:  Med J Aust       Date:  1972-01-01       Impact factor: 7.738

5.  Chlorama-like ocular manifestations in Turkish children with acute myelomonocytic leukaemia.

Authors:  A O Cavdar; S Gözdasoğlu; A Arcasoy; B Demirağ
Journal:  Lancet       Date:  1971-04-03       Impact factor: 79.321

6.  Rarity of Ewing's tumour in Negroes.

Authors:  R D Jensen; R M Drake
Journal:  Lancet       Date:  1970-04-11       Impact factor: 79.321

7.  Wilms' tumor and congenital hemihypertrophy: report of five new cases and review of literature.

Authors:  J F Fraumeni; C F Geiser; M D Manning
Journal:  Pediatrics       Date:  1967-11       Impact factor: 7.124

8.  Primary carcinoma of the liver in childhood: an epidemiologic study.

Authors:  J F Fraumeni; R W Miller; J A Hill
Journal:  J Natl Cancer Inst       Date:  1968-05       Impact factor: 13.506

  8 in total
  1 in total

1.  Synchronous occurrence of glioblastoma multiforme in a husband and wife.

Authors:  T W Griffin; T W Smith; B S Levy; L D Recht
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.